Sestamibi/iodine subtraction single photon emission computed tomography in reoperative secondary hyperparathyroidism

This publication has 23 references indexed in Scilit:

• Parathyroid Detection in Secondary Hyperparathyroidism with 123I/99mTc-Sestamibi Subtraction Single Photon Emission Computed Tomography
  Journal of Clinical Endocrinology & Metabolism, 1998
• Secondary hyperparathyroidism: detection with I-123-Tc-99m-Sestamibi subtraction scintigraphy versus US.
  Radiology, 1998
• Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
  American Journal of Roentgenology, 1997
• Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure
  Nephrology Dialysis Transplantation, 1997
• Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging.
  Radiology, 1995
• 99Tcm sestamibi — a new agent for parathyroid imaging
  Nuclear Medicine Communications, 1989
• Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure
  Kidney International, 1988
• Results of subtotal parathyroidectomy in hemodialysis patients
  The American Journal of Medicine, 1988
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984
• Location of parathyroid adenomas by thallium-201 and technetium-99m subtraction scanning.
  BMJ, 1983